Last updated on November 2018

Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck


Brief description of study

Prevention of critical weight loss. In patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) weight loss is a relevant clinical problem during radiotherapy and might result in higher treatment related toxicity and discontinuation of a potential curative treatment. Thus the investigators want to evaluate the efficacy of overnight parenteral nutritional (PN) support in patients with SCCHN treated with curative radiotherapy (RTX) in combination with Cetuximab (E) or Cisplatin (P).

Detailed Study Description

The investigators hypothesize that about 60% of patients receiving RTX without supplemental PN will suffer from critical weight loss of more than 5% during treatment - supplemental overnight PN might result in significant improvement of the nutritional status .

Clinical Study Identifier: NCT02236936

Contact Investigators or Research Sites near you

Start Over

Johannes Reiß-Kornfehl, Prof.Dr.

Landesklinikum Wiener Neustadt
Wiener Neustadt, Austria
0.68miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.